(1)

Commission Directive 2006/64/CE (2) included trinexapac as an active substance in Annex I to Council Directive 91/414/EEC (3).

(2)

Active substances included in Annex I to Directive 91/414/EEC are deemed to have been approved under Regulation (EC) No 1107/2009 and are listed in Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011 (4).

(3)

The approval of the active substance trinexapac, as set out in Part A of the Annex to Implementing Regulation (EU) No 540/2011, expires on 15 December 2024.

(4)

An application for the renewal of the approval of trinexapac, more specifically as the ethyl ester trinexapac-ethyl, was submitted to Lithuania, the rapporteur Member State, and Latvia, the co-rapporteur Member State, in accordance with Article 1 of Commission Implementing Regulation (EU) No 844/2012 (5) within the time period provided for in that Article.

(5)

The applicant submitted the supplementary dossiers required to the rapporteur Member State, the co-rapporteur Member State, the Commission and the European Food Safety Authority (‘the Authority’) in accordance with Article 6 of Implementing Regulation (EU) No 844/2012. The application was found to be admissible by the rapporteur Member State.

(6)

The rapporteur Member State prepared a draft renewal assessment report in consultation with the co-rapporteur Member State and submitted it to the Authority and the Commission on 31 March 2017. In its draft renewal assessment report, the rapporteur Member State proposed to renew the approval of trinexapac-ethyl.

(7)

The Authority made the supplementary summary dossier available to the public. The Authority also circulated the draft renewal assessment report to the applicant and to the Member States for comments and launched a public consultation on it. The Authority forwarded the comments received to the Commission.

(8)

On 16 March 2018, the Authority communicated to the Commission its conclusion (6) on whether trinexapac-ethyl can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009.

(9)

The Commission presented a draft renewal report for trinexapac-ethyl to the Standing Committee on Plants, Animals, Food and Feed on 23 October 2018.

(10)

In its conclusion, the Authority had concluded that the interim criteria laid down in point 3.6.5 of Annex II to Regulation (EC) No 1107/2009, for the determination of endocrine disrupting properties, were not met. However, it had also identified data gaps and therefore could not finalise the assessment of endocrine disrupting properties.

(11)

Commission Regulation (EU) 2018/605 (7) amended Annex II to Regulation (EC) No 1107/2009 by introducing new scientific criteria for the determination of endocrine disrupting properties. The Commission, thus, requested the Authority, in accordance with Article 14(1a), first subparagraph, of Implementing Regulation (EU) No 844/2012, to update the assessment concerning the endocrine disrupting properties and request additional information from the applicant if needed.

(12)

On 8 June 2023, the Authority communicated to the Commission its updated conclusion (8) on whether trinexapac-ethyl can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009. In its conclusion, the Authority concluded that trinexapac-ethyl does not meet the criteria to consider a substance as having endocrine disrupting properties.

(13)

The Commission presented an updated draft renewal report for trinexapac-ethyl to the Standing Committee on Plants, Animals, Food and Feed on 12 July 2023.

(14)

The Commission invited the applicant to submit its comments on the conclusion of the Authority and, in accordance with Article 14(1), third subparagraph, of Implementing Regulation (EU) No 844/2012, on the renewal report. The applicant submitted its comments, which have been carefully examined and taken into consideration.

(15)

It has been established with respect to one or more representative uses of at least one plant protection product containing trinexapac-ethyl that the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009 are satisfied.

(16)

It is therefore appropriate to renew the approval of trinexapac as trinexapac-ethyl.

(17)

Although, the risk assessment for the renewal of the approval of trinexapac-ethyl is based on a limited number of representative uses, this does not restrict the uses for which plant protection products containing trinexapac-ethyl may be authorised. It is therefore appropriate to remove the restriction for use only as a plant growth regulator.

(18)

In accordance with Article 14(1) of Regulation (EC) No 1107/2009, in conjunction with Article 6 thereof, and in the light of current scientific and technical knowledge, it is, however, necessary to provide for certain conditions and restrictions. It is, in particular, appropriate to set specific maximum limits for two toxicologically relevant impurities in the technical material and to require confirmatory information on the impact of water treatment processes on the nature of residues of trinexapac-ethyl and its metabolites present in surface water when surface water is abstracted for drinking water, since appropriate guidance was not available at the time of the application for renewal of the approval.

(19)

Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.

(20)

Commission Implementing Regulation (EU) 2023/689 (9) extended the approval period of trinexapac to 15 December 2024 in order to allow the renewal process to be completed before the expiry of the approval period of that active substance. However, given that a decision on the renewal of the approval of that active substance has been taken ahead of that extended expiry date, this Regulation should apply earlier than that date.

(21)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,